Loading clinical trials...
Loading clinical trials...
Measurable Residual Disease Detection by Next-generation Sequencing of T Cell Receptor Gene Rearrangements in Pediatric T-cell Acute Lymphocytic Leukemia
Conditions
Interventions
MRD
Locations
1
China
The Children's Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Start Date
February 1, 2018
Primary Completion Date
December 31, 2022
Completion Date
December 31, 2022
Last Updated
July 29, 2024
NCT07108868
NCT06421155
NCT06559345
NCT06722638
NCT05809284
NCT06334835
Lead Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions